Nemvaleukin alfa
- Generic Name
- Nemvaleukin alfa
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2315268-27-8
- Unique Ingredient Identifier
- 7ZX1Q9SJ1F
- Associated Conditions
- -
- Associated Therapies
- -
A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Mural Oncology, Inc
- Target Recruit Count
- 14
- Registration Number
- NCT04144517
- Locations
- 🇺🇸
Mural Oncology Investigational Site, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath